759_360x504
Mark Wegter

Chairman of the Supervisory Board

Mr. Wegter became a member and chairman of our Supervisory Board in 2001. Mr. Wegter graduated from the Erasmus University of Rotterdam, The Netherlands, with a degree in economics. In 1998, Mr. Wegter joined Life Sciences Partners, becoming a general partner in 2001. In that same year Mr. Wegter established Life Sciences Partners’ office in Munich, Germany.

Berndt Modig Prosensa
Berndt Modig

Vice-Chairman of the Supervisory Board and Chairman of the Supervisory Board’s Audit Committee

Mr. Modig became a member of our Supervisory Board in 2016. Mr. Modig was previously Chief Financial Officer of Prosensa Holding N.V. and before that Chief Financial Officer at Jerini AG. He is now also a Board Member of Axovant Sciences Ltd., Auris Medical AG and Affimed N.V., and CEO of Pharvaris B.V.

Stuart-Chapman-642x352
Stuart Chapman

Supervisory Board Member

Mr. Chapman became a member of our Supervisory Board in 2013. Mr. Chapman graduated from the University of Loughborough, United Kingdom, with a degree in economics. Mr. Chapman co‑founded DFJ Esprit in 2006 and has been managing partner of DFJ Esprit since that date.

722_360x504
Martijn Kleijwegt

Supervisory Board Member, Chairman of the Supervisory Board’s Nomination and Remuneration Committee and member of the Supervisory Board’s Audit Committee

Mr. Kleijwegt became a member of our Supervisory Board in 2006. Mr. Kleijwegt graduated from the University of Amsterdam, The Netherlands, with a degree in economics. Mr. Kleijwegt founded Life Sciences Partners in 1998 and has been managing partner of Life Sciences Partners since that date.

Amy Emmert and Robert Soiffer, M.D., of hematologic oncology. Shared Care photo shoot.
Dr. Robert Soiffer

Supervisory Board Member and member of the Supervisory Board’s Nomination and Remuneration Committee

Dr. Soiffer became a member of our Supervisory Board in 2016. Dr. Soiffer is a medical oncologist and Professor of Medicine at the Harvard Medical School, Chief of the Division of Hematologic Malignancies at the Dana-Farber Cancer Institute and Co-director of the Adult Stem Cell Transplantation Program at the Dana-Farber Cancer Institute.